Bumetanide is indicated for:
Whenever diuretic therapy is required in the treatment of oedema, e.g. that associated with congestive heart failure, cirrhosis of the liver and renal disease including nephrotic syndrome.
Summary of Product Characteristics
Read this summary of product characteristics for further information about Bumetanide Liquid Oral Solution. Click below to navigate to the EMC.
Patient Information Leaflet
Read this patient information leaflet about Bumetanide Liquid Oral Solution, what it’s used for and possible side effects. Click below to navigate to the EMC.
Bumetanide Oral Solution
|Click here for Audio Version
|Store below 25°C
|Shelf Life (Closed Bottle)
For further product information and pricing please use the form below and a member of the team will be in touch
Stay updated via our App
A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.